2024 Q2 Form 10-Q Financial Statement

#000143774924017038 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $123.1K $202.5K
YoY Change 5.11% 32.83%
Cost Of Revenue $21.35K $14.19K
YoY Change -20.84% 23.93%
Gross Profit $109.7K $190.6K
YoY Change 21.71% 35.23%
Gross Profit Margin 89.13% 94.16%
Selling, General & Admin $2.243M $2.450M
YoY Change 44.92% 40.38%
% of Gross Profit 2044.67% 1285.15%
Research & Development $3.492M $2.845M
YoY Change 10.14% -16.26%
% of Gross Profit 3182.38% 1492.7%
Depreciation & Amortization $2.170K $2.177K
YoY Change -54.98% -54.82%
% of Gross Profit 1.98% 1.14%
Operating Expenses $3.492M $2.845M
YoY Change 10.14% -16.26%
Operating Profit -$5.636M -$5.121M
YoY Change 21.64% 2.28%
Interest Expense -$195.9K $237.6K
YoY Change 5480.63% 475040.0%
% of Operating Profit
Other Income/Expense, Net -$345.6K $778.0K
YoY Change 9736.69% 1655217.02%
Pretax Income -$5.981M -$4.343M
YoY Change 29.0% -13.26%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.981M -$4.343M
YoY Change 29.0% -13.26%
Net Earnings / Revenue -4858.7% -2145.25%
Basic Earnings Per Share -$0.21 -$0.15
Diluted Earnings Per Share -$0.21 -$0.15
COMMON SHARES
Basic Shares Outstanding 28.62M 28.72M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.122M $2.995M
YoY Change 33.31% 227.28%
Cash & Equivalents $1.122M $2.995M
Short-Term Investments
Other Short-Term Assets $3.004M $3.261M
YoY Change -11.17% 20.66%
Inventory $241.0K $242.5K
Prepaid Expenses
Receivables $83.74K $71.32K
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.450M $6.570M
YoY Change -2.14% 64.52%
LONG-TERM ASSETS
Property, Plant & Equipment $22.17K $24.34K
YoY Change -51.34% -51.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $267.7K $593.8K
YoY Change 182.71% 472.29%
TOTAL ASSETS
Total Short-Term Assets $4.450M $6.570M
Total Long-Term Assets $267.7K $593.8K
Total Assets $4.718M $7.164M
YoY Change 1.63% 74.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.860M $3.671M
YoY Change -36.5% -18.11%
Accrued Expenses $1.577M $1.746M
YoY Change 8927.36% 10187.8%
Deferred Revenue
YoY Change
Short-Term Debt $2.711M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.829M $6.536M
YoY Change 61.24% 45.27%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $12.38K $17.51K
YoY Change -61.24% -52.07%
Total Long-Term Liabilities $12.38K $17.51K
YoY Change -61.25% -52.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.829M $6.536M
Total Long-Term Liabilities $12.38K $17.51K
Total Liabilities $9.841M $6.554M
YoY Change 60.6% 44.48%
SHAREHOLDERS EQUITY
Retained Earnings -$94.18M -$88.20M
YoY Change 28.24% 28.19%
Common Stock $0.00 $0.00
YoY Change -100.0% -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.123M $610.0K
YoY Change
Total Liabilities & Shareholders Equity $4.718M $7.164M
YoY Change 1.63% 74.85%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$5.981M -$4.343M
YoY Change 29.0% -13.26%
Depreciation, Depletion And Amortization $2.170K $2.177K
YoY Change -54.98% -54.82%
Cash From Operating Activities -$3.848M -$6.182M
YoY Change 10.62% 41.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.975M -$69.28K
YoY Change -42.0% -101.85%
NET CHANGE
Cash From Operating Activities -3.848M -$6.182M
Cash From Investing Activities
Cash From Financing Activities 1.975M -$69.28K
Net Change In Cash -1.873M -$6.251M
YoY Change 2443.61% 895.06%
FREE CASH FLOW
Cash From Operating Activities -$3.848M -$6.182M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9246592 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17507 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
17507 usd
CY2024Q1 us-gaap Salaries And Wages
SalariesAndWages
822481 usd
CY2023Q1 us-gaap Salaries And Wages
SalariesAndWages
906955 usd
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2995000 usd
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000922247
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2995000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6182000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-88200000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-4343000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10272 usd
CY2023Q4 us-gaap Assets
Assets
13247538 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1010631 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5888813 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6536369 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28614384
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28614384
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28556072
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28556072
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
2862 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
2856 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
88806896 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
88610832 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-88199744 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-83856681 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
610014 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4757007 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7163890 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13247538 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
202450 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
152411 usd
CY2024Q1 ctdh Cost Of Goods And Services Sold Excluding Direct And Indirect Overhead And Handling Costs
CostOfGoodsAndServicesSoldExcludingDirectAndIndirectOverheadAndHandlingCosts
11823 usd
CY2023Q1 ctdh Cost Of Goods And Services Sold Excluding Direct And Indirect Overhead And Handling Costs
CostOfGoodsAndServicesSoldExcludingDirectAndIndirectOverheadAndHandlingCosts
10196 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
190627 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
142215 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2845483 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3398167 usd
CY2024Q1 ctdh Repairs And Maintenance
RepairsAndMaintenance
2363 usd
CY2023Q1 ctdh Repairs And Maintenance
RepairsAndMaintenance
1252 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
630388 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
482835 usd
CY2024Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
892213 usd
CY2023Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
282375 usd
CY2024Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
104398 usd
CY2023Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
72125 usd
CY2024Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2177 usd
CY2023Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
4819 usd
CY2024Q1 ctdh Freight And Shipping
FreightAndShipping
373 usd
CY2023Q1 ctdh Freight And Shipping
FreightAndShipping
819 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-11813 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-0 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
5311689 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
5149347 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5121062 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5007132 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
237568 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
47 usd
CY2024Q1 us-gaap Lease Income
LeaseIncome
540431 usd
CY2023Q1 us-gaap Lease Income
LeaseIncome
0 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
777999 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
47 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4343063 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5007085 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-4343063 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5007085 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28585228
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11003588
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4757007 usd
CY2024Q1 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
69281 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
173218 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-4343063 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
610014 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
734544 usd
CY2023Q1 ctdh Stock Issued During Period Value Common Stock And Prefunded Warrants
StockIssuedDuringPeriodValueCommonStockAndPrefundedWarrants
3741883 usd
CY2023Q1 ctdh Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
114 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
91668 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5007085 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-438876 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-4343063 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5007085 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2177 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4819 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-11813 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-0 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
173218 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
91668 usd
CY2024Q1 ctdh Sharebased Compensation Nonemployees
SharebasedCompensationNonemployees
92133 usd
CY2023Q1 ctdh Sharebased Compensation Nonemployees
SharebasedCompensationNonemployees
0 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-51057 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
76233 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-11822 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9994 usd
CY2024Q1 ctdh Increase Decrease Prepaid Clinical Expenses
IncreaseDecreasePrepaidClinicalExpenses
508159 usd
CY2023Q1 ctdh Increase Decrease Prepaid Clinical Expenses
IncreaseDecreasePrepaidClinicalExpenses
309403 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
104528 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
87503 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-0 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1573 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1568603 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1001931 usd
CY2024Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-1839070 usd
CY2023Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
636846 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6182133 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4370239 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
2407849 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1334034 usd
CY2024Q1 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
69281 usd
CY2023Q1 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
-0 usd
CY2024Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
CY2023Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
114 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-69281 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3741997 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6251414 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-628242 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9246592 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1543418 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2995178 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
915176 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
756 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1730 usd
CY2024Q1 ctdh Working Capital Deficit
WorkingCapitalDeficit
34000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
10000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
202450 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
152411 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3670646 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4856530 usd
CY2024Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
996161 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1590776 usd
CY2024Q1 ctdh Accrued Board Expense Current
AccruedBoardExpenseCurrent
102125 usd
CY2023Q4 ctdh Accrued Board Expense Current
AccruedBoardExpenseCurrent
92110 usd
CY2024Q1 us-gaap Deposit Liability Current
DepositLiabilityCurrent
243742 usd
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
243742 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
487342 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
487402 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
388797 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
186856 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5888813 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7457416 usd
CY2024Q1 ctdh Operating Lease Right Of Usse Asset Amortization
OperatingLeaseRightOfUsseAssetAmortization
321472 usd
CY2023Q4 ctdh Operating Lease Right Of Usse Asset Amortization
OperatingLeaseRightOfUsseAssetAmortization
17242 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
527417 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
9535 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-4343063 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5007085 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
28585228
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
11003588
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2024Q1 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
980000 usd

Files In Submission

Name View Source Status
0001437749-24-017038-index-headers.html Edgar Link pending
0001437749-24-017038-index.html Edgar Link pending
0001437749-24-017038.txt Edgar Link pending
0001437749-24-017038-xbrl.zip Edgar Link pending
ctdh-20240331.xsd Edgar Link pending
ctdh20240331_10q.htm Edgar Link pending
ex_670355.htm Edgar Link pending
ex_670356.htm Edgar Link pending
ex_670357.htm Edgar Link pending
ex_670358.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
ctdh-20240331_def.xml Edgar Link unprocessable
ctdh-20240331_lab.xml Edgar Link unprocessable
ctdh-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ctdh20240331_10q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ctdh-20240331_cal.xml Edgar Link unprocessable